unknown
Stage
About
Altido Therapeutics is a clinical-stage biotech company developing a novel CAR-TEAM T cell-based immunotherapy platform to treat difficult-to-treat solid tumors such as glioblastoma by targeting tumors with genetically engineered CAR-T cells that secrete T-cell engaging molecules.
Explore Altido Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.